Plain-English translation of NCT06387199 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a medication called semaglutide, given as a weekly injection, can help people with type 1 diabetes simplify their daily routine. Right now, people using insulin pump systems have to carefully count carbohydrates in meals so the pump can deliver the right amount of insulin. The study wants to see if this medication can reduce or even eliminate that carbohydrate counting while keeping blood sugar under good control.
Counting carbohydrates is one of the hardest parts of managing type 1 diabetes and can be stressful and error-prone. Researchers believe this medication might help the body manage blood sugar more naturally, reducing the mental burden of constant carbohydrate tracking.
You likely qualify if…
You likely don't qualify if…
You will receive either the study medication or a placebo as a weekly injection that you give yourself. Over several weeks, you'll try four different meal management approaches — some requiring full carbohydrate counting, others using the medication with different insulin types, and one with a fully automated system. The study lasts several months total, and you'll meet with the research team to check your blood sugar control and see how well the medication is working for you.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Canada